Astria Therapeutics Shares Are Trading Higher After the Company Announced Initial Proof-of-concept Results From the ALPHA-STAR Phase 1b/2 Clinical Trial Evaluating STAR-0215 in HAE Patients
Astria Therapeutics 公布了评估 HAE 患者中 STAR-0215 的 ALPHA-STAR 1b/2 期临床试验的初步概念验证结果后,该公司股价走高